Literature DB >> 10022678

Multiple sclerosis and the urologist.

S E Litwiller1, E M Frohman, P E Zimmern.   

Abstract

PURPOSE: We provide an updated reference detailing the neurological and urological state of the art approach to multiple sclerosis (MS) with special emphasis on the pathology and physiology, effects on the genitourinary tract, diagnostic evaluation, and treatment of neurological and urological manifestations.
MATERIALS AND METHODS: A MEDLINE computerized reference search and manual bibliography review were performed to find pertinent peer reviewed articles on the neurological and urological manifestations and treatment of MS. A meta-analysis was performed on the urodynamic findings of 22 studies involving 1,882 patients from well-defined MS populations.
RESULTS: The majority of patients with MS have genitourinary symptoms ranging from urgency, urge incontinence and frequency to urinary retention. Symptoms do not accurately reflect the underlying urological pathology but parallel pyramidal tract dysfunction. Urodynamic evaluation has an important role in determining proper bladder management. The most common urodynamic finding is detrusor hyperreflexia in 62% of these patients, followed by detrusor-sphincter dyssynergia in 25% and hypocontractility in 20%. Less than 1% of patients has renal deterioration and most may be treated with conservative measures. If conservative measures fail, new forms of bladder reconstruction and diversion may be effectively used. The incidence of sexual dysfunction is up to 80% in men and 72% in women, and treatment focuses on improvement of overall disability and erectile or orgasmic function.
CONCLUSIONS: Although the genitourinary consequences of MS are rarely life threatening, they can cause significant morbidity and patient frustration. With the rapid advances in the medical management of MS the urologist should be actively involved in multispecialty treatment of these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10022678

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  54 in total

Review 1.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

Review 3.  Underactive Bladder.

Authors:  Himanshu Aggarwal; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

4.  The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Authors:  Bhupendra O Khatri; John F Foley; Jennifer Fink; John F Kramer; Choon Cha; Xiaojun You; John D Warth; Pam Foulds
Journal:  Int J MS Care       Date:  2014

Review 5.  Botox in urology.

Authors:  Ali Thwaini; Iqbal Shergill; Suresh Radhakrishnan; Frank Chinegwundoh; Hadeel Thwaini
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-19

Review 6.  Pathophysiology of overactive bladder.

Authors:  Mai A Banakhar; Tariq F Al-Shaiji; Magdy M Hassouna
Journal:  Int Urogynecol J       Date:  2012-02-07       Impact factor: 2.894

7.  Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen.

Authors:  Carlos Arturo Levi D'Ancona; José Tadeu Tamanini; Neury Botega; Nivaldo Lavoura; Ruiter Ferreira; Victor Leitão; Maria Helena Baena M Lopes
Journal:  Int Urol Nephrol       Date:  2008-06-05       Impact factor: 2.370

Review 8.  Augmentation cystoplasty: what are the indications?

Authors:  Polina Reyblat; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

Review 9.  Botulinum toxin for symptomatic therapy in multiple sclerosis.

Authors:  Michelle H Cameron; Francois Bethoux; Nina Davis; Meredith Frederick
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

10.  Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Authors:  A Ghezzi; E Mutta; F Bianchi; S Bonavita; F Buttari; A Caramma; R Cavarretta; D Centonze; G C Coghe; G Coniglio; U Del Carro; M T Ferrò; M G Marrosu; F Patti; M Rovaris; M Sparaco; I Simone; C Tortorella; R Bergamaschi
Journal:  Neurol Sci       Date:  2015-11-27       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.